Clinical Trials Directory

Trials / Unknown

UnknownNCT06144138

Impact of Breathing Exercises and Meditation on Reducing Stress and Improving Quality of Life of Glaucoma Patients: An Electronic Pilot Feasibility Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Academic / Other
Sex
All
Age
40 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The goal of this electronic feasibility clinical trial study is to evaluate the effects of breathing and meditation techniques on stress levels in patients with glaucoma. The main questions it aims to answer are: * Does breathing and meditation decrease the level of stress in glaucoma patients? * Does breathing and meditation improve disease specific quality of life in glaucoma patients * Does breathing and meditation affect the importance that in glaucoma patients place on future consequences? Participants will participate in online session where they will be taught proper breathing and meditation technique to practice. They will also be completing online questionnaires following independent practice sessions over time. Researchers will compare the breathing and meditation group to the usual care group to see if the outcomes are different.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBreathing Exercises followed by MeditationBreathing exercises and Meditation taught by Prasanna Wellness, a non-profit organization, helps dissolve stress and create a proper system in the mind. These breathing exercises include slow deep breaths and rapid breaths and are followed by meditation. Meditation is a guided meditation that helps to eliminate stress and establish an apposite system in the mind, therefore inducing physiological and mental relaxation whilst the eyes are shut. The proposed duration and frequency of the follow-up will be 60-minutes weekly for 11 weeks.

Timeline

Start date
2024-05-01
Primary completion
2025-09-01
Completion
2025-11-01
First posted
2023-11-22
Last updated
2023-11-22

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06144138. Inclusion in this directory is not an endorsement.